Yissum Ltd. Introduces a Novel Method for Diagnosing Retinal Micro-Aneurysms to Prevent Diabetic Retinopathy
6/10/2013 9:57:35 AM
More...
|
Yissum Ltd. Announces Formation of Integra Holdings, a Biopharmaceutical Holding Company
10/31/2012 7:41:42 AM
More...
|
Yissum Ltd. Signs Licensing Agreement with Dow AgroFresh for a Novel Water-Soluble Compound that Antagonizes the Action of the Plant Hormone Ethylene
3/5/2012 7:56:04 AM
More...
|
Yissum Ltd. to Collaborate with BioConnections for the Commercialization of Kits for Identifying Antibiotic Resistant Infections
2/27/2012 6:12:37 AM
More...
|
Yissum Ltd. Introduces a Novel Technology for Manufacturing an Anti-Malaria Drug in Tobacco
12/19/2011 6:22:08 AM
More...
|
Yissum Ltd. Out-Licenses a Breakthrough Seed Improvement Technology to Morflora
11/2/2011 8:00:02 AM
More...
|
Yissum Ltd. Introduces Novel Markers for Brain Cancer Survival Prognosis and a New Treatment Method for the Disease
7/28/2011 7:54:37 AM
More...
|
BioLineRx Ltd. Signs Exclusive License Agreement with Yissum Ltd. for Oral Phase II Ready Treatment BL-7040 for Inflammatory Bowel Disease
6/27/2011 9:20:14 AM
More...
|
Yissum Ltd. Presents a Virtual Cane for the Visually Impaired
6/21/2011 9:19:15 AM
More...
|
Yissum Ltd. Presents Promising Pre-Clinical Results for Oral Delivery of the Anti-Cancer Drug Docetaxel Using a Novel Nanotechnology Approach
4/12/2011 12:14:56 PM
More...
|
|